Suspended

Role and Outcome of Endovascular Revacularization of Chronic Limb Threatening Ischaemia in Patients With Chronic Kidney Diseases

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Chronic Limb-Threatening Ischemia+10

+ Arterial Occlusive Diseases

+ Arteriosclerosis

From 18 to 75 Years
+4 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: December 2022
See protocol details

Summary

Principal SponsorMahmoud Abdelmohsen Mostafa Osman
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: December 1, 2022

Actual date on which the first participant was enrolled.

patients with chronic kidney diseases are at higher risk of developing peripheral artery diseases needing revascularization of diseased arteries via endovascular transluminal angioplasty

Official TitleRole and Outcome of Endovascular Revacularization of Chronic Limb Threatening Ischaemia in Patients With Chronic Kidney Diseases
NCT05643378
Principal SponsorMahmoud Abdelmohsen Mostafa Osman
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

100 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 75 Years

Range of ages for which participants are eligible to join.

Conditions

Pathology

Chronic Limb-Threatening IschemiaArterial Occlusive DiseasesArteriosclerosisCardiovascular DiseasesChronic DiseaseIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsVascular DiseasesPeripheral Vascular DiseasesDisease AttributesAtherosclerosisPeripheral Arterial Disease

Criteria

1 inclusion criteria required to participate
all patients with chronic kidney diseases on medical treatment or on dialysis and have critical limb ischaemia
3 exclusion criteria prevent from participating
patients with acute renal failure and lower limb ischaemia.
chronic kidney diseased patients underwent previous intervention or surgery for lower limb ischaemia.
patients presented with acute limb ischaemia

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has no location dataSave this study to your profile to know when the location data is available.
SuspendedNo study centers